Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 28, Pages 23356-23367Publisher
ELSEVIER
DOI: 10.1074/jbc.M112.340505
Keywords
-
Categories
Funding
- National Institutes of Health [R01 DK078965, HL093269]
Ask authors/readers for more resources
Promyelocytic leukemia protein (PML) is a tumor suppressor that is highly expressed in vascular endothelium and inflamed tissues, yet its role in inflammation-associated cytokine-regulated angiogenesis and underlying mechanism remains largely unclear. We show that tumor necrosis factor alpha (TNF alpha) and interferon alpha (IFN alpha) stimulate PML expression while suppressing EC network formation and migration, two key events during angiogenesis. By a knockdown approach, we demonstrate that PML is indispensable for TNF alpha- and IFN alpha-mediated inhibition of EC network formation. We further demonstrate that signal transducer and activator of transcription 1 (STAT1) binds PML promoter and that is an important regulator of PML expression. Knockdown of STAT1 reduces endogenous PML and blocks TNF alpha- and IFN alpha-induced PML accumulation and relieves TNF alpha- and IFN alpha-mediated inhibition of EC network formation. Our data also indicate that PML regulates EC migration, in part, by modulating expression of downstream genes, such as negatively regulating integrin beta 1 (ITGB1). In addition, knockdown of STAT1 or PML alleviates TNF alpha- and IFN alpha-mediated inhibition of ITGB1 expression. Antibody blockade demonstrates that ITGB1 is functionally important for PML- and STAT1-regulated EC migration. Taken together, our data provide novel mechanistic insights that PML functions as a negative regulator in EC network formation and migration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available